Xihua Yuan, Xiaofeng Qin, Lulu Tang, Zhiyu Kong, Min Deng, Yi Wu
Department of Dermatology and Venerology, The Second Affiliated Hospital, Guangxi Medical University, Nanning, China.
Guangxi Clinical Research Center for Craniofacial Deformity, College of Stomatology, Hospital of Stomatology, Guangxi Medical University, Nanning, China.
Mycoses. 2025 Feb;68(2):e70004. doi: 10.1111/myc.70004.
Fungal skin diseases are a significant burden in Asia, with varying trends from 1990 to 2019, highlighting the need for targeted interventions.
To investigate long-term trends in the incidence, prevalence and disability-adjusted life-year rates for fungal skin diseases in China, India, Japan and Singapore from 1990 to 2019.
PATIENTS/METHODS: Data were obtained from the 2019 Global Burden of Disease Study. Independent age, period and cohort effects were calculated using age-period-cohort analysis.
Age-standardised incidence, prevalence and disability-adjusted life-year rates of fungal skin diseases in China, India, Japan and Singapore decreased from 1990 to 2019. India has the highest standardised incidence, prevalence and disability-adjusted life-year rates. The crude incidence, prevalence and disability-adjusted life-year rates showed an increasing trend in China, Japan and Singapore, and a decreasing trend in India. The age-period-cohort analysis found that the age effect increased in China, Japan and Singapore at ages 45-94 years, and India showed higher risk coefficients at ages 5-20 and 45-94 years. The period effect increased in the four countries, with more pronounced increases in Japan and Singapore. The cohort effect showed a monotonic decline with birth cohort in the four countries, with a slightly slower decline in India.
Fungal skin diseases pose a serious burden in Asian countries. We recommend raising awareness and providing specialised interventions for fungal skin diseases, especially for high-risk groups, such as middle-aged and older adults aged ≤ 45 years and young Indians aged ≤ 20 years.
真菌性皮肤病在亚洲是一项重大负担,1990年至2019年呈现出不同的趋势,这凸显了针对性干预措施的必要性。
调查1990年至2019年中国、印度、日本和新加坡真菌性皮肤病的发病率、患病率和伤残调整生命年率的长期趋势。
患者/方法:数据来自2019年全球疾病负担研究。使用年龄-时期-队列分析计算独立的年龄、时期和队列效应。
1990年至2019年,中国、印度、日本和新加坡真菌性皮肤病的年龄标准化发病率、患病率和伤残调整生命年率均有所下降。印度的标准化发病率、患病率和伤残调整生命年率最高。中国、日本和新加坡的粗发病率、患病率和伤残调整生命年率呈上升趋势,而印度呈下降趋势。年龄-时期-队列分析发现,中国、日本和新加坡45-94岁人群的年龄效应增加,印度在5-20岁和45-94岁人群中显示出较高的风险系数。四个国家的时期效应均增加,日本和新加坡的增加更为明显。四个国家的队列效应随出生队列呈单调下降,印度的下降略慢。
真菌性皮肤病在亚洲国家造成严重负担。我们建议提高对真菌性皮肤病的认识并提供专门干预措施,特别是针对高危人群,如年龄≤45岁的中年及老年人和年龄≤20岁的印度年轻人。